3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
25
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Myelodysplastic Syndromes
16
Hodgkin Disease
13
Lymphoma, Non-Hodgkin
11
Lymphoma, Large B-Cell, Diffuse
8
Lymphoma
8
Leukemia, Biphenotypic, Acute
8
Leukemia
8
Burkitt Lymphoma
7
Breast Neoplasms
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Neuroblastoma
5
Neoplasms
5
Lymphoma, Mantle-Cell
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Hematologic Neoplasms
5
Triple Negative Breast Neoplasms
4
Sarcoma
4
Rhabdomyosarcoma
4
Multiple Myeloma
4
Lymphoma, Follicular
4
Anemia, Refractory, with Excess of Blasts
4
Medulloblastoma
3
Leukemia, Myelomonocytic, Chronic
3
Carcinoma, Non-Small-Cell Lung
3
Recurrence
2
Myeloproliferative Disorders
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Interventions
Cyclophosphamide
16
Mycophenolic Acid
13
Tacrolimus
10
fludarabine
9
ruxolitinib
8
Busulfan
7
fludarabine phosphate
6
Whole-Body Irradiation
6
Sirolimus
6
Melphalan
6
Methotrexate
5
Thiotepa
4
ibrutinib
3
Specimen Handling
3
Cyclosporine
3
Abatacept
3
Stem Cell Transplantation
2
Radiotherapy
2
Hematopoietic Stem Cell Transplantation
2
Clofarabine
2
Biopsy
2
vedolizumab
1
tildrakizumab
1
itacitinib
1
blinatumomab
1
belumosudil
1
axatilimab
1
Vorinostat
1
Therapeutics
1
Rituximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Graft vs Host Disease
×
Filgrastim
×
1 year
×
Clear all
No trials found.